These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 387234)

  • 21. Is there a place for adjuvant endocrine therapy of breast cancer?
    Meakin JW
    Recent Results Cancer Res; 1980; 71():178-84. PubMed ID: 7367731
    [No Abstract]   [Full Text] [Related]  

  • 22. Combination chemotherapy for metastatic breast cancer: comparison of multiple drug therapy with 5-fluorouracil, cytoxan and prednisone with adriamycin or adrenalectomy.
    Nemoto T; Rosner D; Diaz R; Dao T; Sponzo R; Cunningham T; Horton J; Simon R
    Cancer; 1978 Jun; 41(6):2073-7. PubMed ID: 657080
    [No Abstract]   [Full Text] [Related]  

  • 23. Status of adjuvant chemotherapy in patients with breast cancer.
    Ahmann DL
    Cancer; 1984 Feb; 53(3 Suppl):724-8. PubMed ID: 6362824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase I-II study of concurrent irradiation and multi-drug chemotherapy in advanced carcinoma of the breast: a pilot study by the Southeastern Cancer Study Group.
    Perez CA; Presant C; Philpott G; Ratkin G
    Int J Radiat Oncol Biol Phys; 1979 Aug; 5(8):1329-33. PubMed ID: 118951
    [No Abstract]   [Full Text] [Related]  

  • 25. Combined modality management of operable breast cancer.
    Rossi A; Valagussa P; Bonadonna G
    Recent Results Cancer Res; 1978; 68():80-97. PubMed ID: 379938
    [No Abstract]   [Full Text] [Related]  

  • 26. Combination chemotherapy for advanced breast cancer: two regimens containing adriamycin.
    Kennealey GT; Boston B; Mitchell MS; Knobf MK; Bobrow SN; Pezzimenti JF; Lawrence R; Bertino JR
    Cancer; 1978 Jul; 42(1):27-33. PubMed ID: 667798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination chemotherapy of metastatic breast cancer: a randomized trial comparing the use of adriamycin to that of Vinblastine.
    Bezwoda WR; de Moor NG; Derman D; Lange M; Saner R; Dando R
    Cancer; 1979 Aug; 44(2):392-7. PubMed ID: 383254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Combination chemotherapy in the adjuvant treatment of disseminated breast cancer].
    Sviatukhina OV; Izmaĭlova GE
    Vopr Onkol; 1981; 27(3):43-8. PubMed ID: 7222522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone.
    Mouridsen HT; Palshof T
    Prog Clin Biol Res; 1977; 12():459-66. PubMed ID: 335404
    [No Abstract]   [Full Text] [Related]  

  • 30. A well tolerated oral combination of chlorambucil (Leukeran R), methotrexate, fluorouracil, prednisone (LMFP) in disseminated breast cancer.
    Mayr AC; Jungi WF; Senn HJ
    Cancer Treat Rev; 1979 Jun; 6 Suppl():115-20. PubMed ID: 498164
    [No Abstract]   [Full Text] [Related]  

  • 31. Phase II study of alternating cytoreductive and cycle-active combination chemotherapy for metastatic breast cancer.
    Vogel CL; Love NH; East DR; Moore MR; Smalley RV
    Cancer Treat Rep; 1979; 63(11-12):2077-9. PubMed ID: 526940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pilot study on adjuvant chemotherapy and hormonal therapy for irradiated inoperable breast cancer.
    Schaake C; Engelsman E; Hamersma E
    Recent Results Cancer Res; 1978; 68():113-7. PubMed ID: 379929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NIH consensus-development statement. Adjuvant chemotherapy of breast cancer. The NIH Consensus-Development Panel.
    N Engl J Med; 1980 Oct; 303(14):831-2. PubMed ID: 6997737
    [No Abstract]   [Full Text] [Related]  

  • 34. Levamisole: as adjuvant to cyclic chemotherapy in breast cancer.
    Stephens EJ; Wood HF; Mason B
    Recent Results Cancer Res; 1978; 68():139-45. PubMed ID: 379932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant therapy of stage II, III breast cancer.
    Buzdar AV; Gutterman JU; Blumenschein GR; Tashima CK; Hortobágyi GN; Yap HY; Hersh EM; Gehan EA
    Recent Results Cancer Res; 1978; 68():123-8. PubMed ID: 379930
    [No Abstract]   [Full Text] [Related]  

  • 36. Surgical adjuvant chemotherapy in cancer of the breast: results of a decade of cooperative investigation.
    Fisher B; Ravdin RG; Ausman RK; Slack NH; Moore GE; Noer RJ
    Ann Surg; 1968 Sep; 168(3):337-56. PubMed ID: 4970947
    [No Abstract]   [Full Text] [Related]  

  • 37. Oral adjuvant therapy in breast carcinoma--a multicentre trial.
    Leiberman DP; Berstock DA; Houghton J; Kearney G
    Cancer Treat Rev; 1979 Jun; 6 Suppl():91-6. PubMed ID: 387233
    [No Abstract]   [Full Text] [Related]  

  • 38. Adriamycin combinations in advanced breast cancer. A Southwest Oncology Group Study.
    Tranum BL; McDonald B; Thigpen T; Vaughn C; Wilson H; Maloney T; Costanzi J; Bickers J; el Mawli NG; Palmer R; Hoogstraten B; Heilburn L; Rasmusen S
    Cancer; 1982 Mar; 49(5):835-9. PubMed ID: 7037152
    [No Abstract]   [Full Text] [Related]  

  • 39. Advanced breast cancer: high-dose chemotherapy and bone marrow autotransplants.
    Antman K; Gale RP
    Ann Intern Med; 1988 Apr; 108(4):570-4. PubMed ID: 3279894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant chemotherapy of breast cancer.
    Kennedy BJ
    Minn Med; 1979 Jul; 62(7):509-11. PubMed ID: 492097
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.